Diagnosis of acquired aplastic anemia (Q38061043)

28 August 2017

1 reference

title

Diagnosis of acquired aplastic anemia (English)

1 reference

28 August 2017

A Rovó

1

1 reference

28 August 2017

A Tichelli

series ordinal

2

1 reference

28 August 2017

C Dufour

series ordinal

3

1 reference

28 August 2017

SAA-WP EBMT

series ordinal

4

1 reference

28 August 2017

language of work or name

English

0 references

publication date

19 November 2012

1 reference

Bone Marrow Transplantation

28 August 2017

published in

1 reference

28 August 2017

volume

48

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

162-167

1 reference

Current concepts in the pathophysiology and treatment of aplastic anemia

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Clinical approach to marrow failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Myelodysplastic and myeloproliferative disorders in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Late clonal diseases of treated aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Late clonal complications in severe aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Dyskeratosis Congenita: a historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Advances in the understanding of dyskeratosis congenita

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Fanconi anemia and its diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Paroxysmal nocturnal hemoglobinuria from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

HLA-DR2 Frequency Increase in Severe Aplastic Anemia Patients is Mainly Attributed to the Prevalence of DR15 Subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Roles of DRB1 *1501 and DRB1 *1502 in the pathogenesis of aplastic anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Flaviviruses and bone marrow failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Hepatitis associated aplastic anemia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Analysis of T-cell repertoire in hepatitis-associated aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Eosinophilic fasciitis 30 years after - what do we really know? Report of 11 patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Coincidence of severe aplastic anaemia with multiple sclerosis or thyroid disorders. Report of 5 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Retrospective survey on the prevalence and outcome of prior autoimmune diseases in patients with aplastic anemia reported to the registry of the European group for blood and marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Predicting response to immunosuppressive therapy in childhood aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

Hematopoiesis in 3 dimensions: human and murine bone marrow architecture visualized by confocal microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

21 January 2018

Acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

7 January 2021

Reference standards for bone marrow cellularity

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

7 January 2021

Aplastic anemia in association with a lymphoproliferative neoplasm: coincidence or causality?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

7 January 2021

Clinical relevance of cytogenetic abnormalities at diagnosis of acquired aplastic anaemia in adults

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

7 January 2021

Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

7 January 2021

Clinical impact of HLA-DR15, a minor population of paroxysmal nocturnal haemoglobinuria-type cells, and an aplastic anaemia-associated autoantibody in children with acquired aplastic anaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

7 January 2021

Hepatitis-associated aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

7 January 2021

Hepatitis-associated aplastic anaemia: epidemiology and treatment results obtained in Europe. A report of The EBMT aplastic anaemia working party

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

7 January 2021

Aplastic anaemia in association with coeliac disease: a series of three cases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

7 January 2021

Aplastic anemia and concomitant autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

7 January 2021

A third course of anti-thymocyte globulin in aplastic anaemia is only beneficial in previous responders

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.230

7 January 2021

Identifiers

DOI

10.1038/BMT.2012.230

1 reference

Dimensions Publication ID

28 August 2017

1007569236

0 references

1 reference